With a market capitalization of $42,520,982,071, Veeva Systems Inc has a greater market value than 95.47% of US stocks.
VEEV's one year PEG ratio, measuring expected growth in earnings next year relative to current common stock price is 863.23 -- higher than 96.22% of US-listed equities with positive expected earnings growth.
The price/operating cash flow metric for Veeva Systems Inc is higher than 96.35% of stocks in our set with a positive cash flow.
Stocks with similar financial metrics, market capitalization, and price volatility to Veeva Systems Inc are SEDG, NVCR, MPWR, HUYA, and QLYS.
VEEV's SEC filings can be seen here. And to visit Veeva Systems Inc's official web site, go to www.veeva.com.
Veeva Systems provides cloud-based software solutions for the life sciences industry in North America, Europe, the Asia Pacific, and Latin America. The company was founded in 2007 and is based in Pleasanton, California.
With thousands of stocks to pick from and a multitude of financial metrics one can use to judge companies' performance and growth potential, how can investors be sure they are making the best possible decisions? For me, "solid" revenue growth means at least 15% year over year, and "sustained" means it has continued for years, not just a few quarters. Since 2016, it has put up annual revenue growth in excess of 45%.
Readers who have followed along know that Veeva Systems was one of our original "virus" plays back when the whole pandemic was just reaching U.S. shores, and thus impacting U.S. financial markets, not to mention deeply impacting human lives and families. To refresh, Veeva is not a pharmaceutical, or a biotech. Veeva is a cloud-based software provider that focuses on the life sciences industry.